Enlivex Randomizes 135 Patients in Phase 2b Allocetra Knee Osteoarthritis Trial
Enlivex announced that 135 patients have been randomized in its Phase 2b trial of Allocetra for age-related moderate-to-severe knee osteoarthritis.
Related stories
BorgWarner shares fall as sales forecast range narrows and Q3 revenue misses
BorgWarner’s sales forecast top end was trimmed, and third-quarter revenue missed expectations.
M impact | EQUITY | Oct 29, 2026, 02:59 PM UTC
Canada stocks fall as miner earnings disappoint and Alphabet weighs on tech
Canada's TSX is lower as miner earnings disappoint and Alphabet drags technology shares.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Ibn Al Haytham Hospital Reports Q3 Revenue of 3.1 Million Dinars
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Landmark Bancorp Q3 2026 Earnings Call Begins
Landmark Bancorp's quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Broadstone Net Lease Q3 2026 Earnings Call Begins
Broadstone Net Lease's quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Forestar Group’s Q4 2026 Earnings Call Begins
Forestar Group’s quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC